CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc.

NASDAQ:CNSP

Overview | Financials
Company Name CNS Pharmaceuticals, Inc.
Symbol CNSP
Currency USD
Price 0.148
Market Cap 4,764,096
Dividend Yield 0%
52-week-range 0.096 - 137.5
Industry Biotechnology
Sector Healthcare
CEO Mr. John Michael Climaco Esq., J.D.
Website https://www.cnspharma.com

An error occurred while fetching data.

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of

Related Stocks

Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp.

LEXX

3.43 USD

Financials

Numbers are in millions USD

Numbers are in millions USD